Clinical Trial Update: Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression [NA]

View source ↗

Summary

Clinical trial evaluating strategies to improve Shingrix vaccination among US veterans who are on immunosuppressive therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: University of California, San Francisco | Conditions: Immunosuppresion | NA | Status: ENROLLING_BY_INVITATION